These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


302 related items for PubMed ID: 7809926

  • 1. Different cellular patterns associated with hepatitis C virus reactivation, cytomegalovirus infection, and acute rejection in liver transplant patients monitored with transplant aspiration cytology.
    Lautenschlager I, Nashan B, Schlitt HJ, Hoshino K, Ringe B, Tillmann HL, Manns M, Wonigeit K, Pichlmayr R.
    Transplantation; 1994 Dec 27; 58(12):1339-45. PubMed ID: 7809926
    [Abstract] [Full Text] [Related]

  • 2. Fine-needle aspiration biopsy in the monitoring of liver allografts. Different cellular findings during rejection and cytomegalovirus infection.
    Lautenschlager I, Höckerstedt K, Salmela K, Isoniemi H, Holmberg C, Jalanko H, Häyry P.
    Transplantation; 1990 Nov 27; 50(5):798-803. PubMed ID: 2173180
    [Abstract] [Full Text] [Related]

  • 3. Evolution of hepatitis C virus in liver allografts.
    Demetris AJ.
    Liver Transpl; 2009 Nov 27; 15 Suppl 2():S35-41. PubMed ID: 19876940
    [Abstract] [Full Text] [Related]

  • 4. ICAM-1 induction on hepatocytes as a marker for immune activation of acute liver allograft rejection.
    Lautenschlager IT, Höckerstedt KA.
    Transplantation; 1993 Dec 27; 56(6):1495-9. PubMed ID: 7904090
    [Abstract] [Full Text] [Related]

  • 5. c-Kit-positive mast cells in portal tracts cannot be used to distinguish acute cellular rejection from recurrent hepatitis C infection in liver allografts.
    Doria C, di Francesco F, Marino IR, Ramirez CB, Frank A, Iaria M, Galati SA, Farber JL.
    Transplant Proc; 2006 Dec 27; 38(10):3597-600. PubMed ID: 17175342
    [Abstract] [Full Text] [Related]

  • 6. [Liver transplant aspiration cytology to monitor the intragraft events].
    Akimaru K, Onda M, Schlitt HJ, Tajiri T.
    Rinsho Byori; 2000 Nov 27; 48(11):1014-21. PubMed ID: 11132554
    [Abstract] [Full Text] [Related]

  • 7. Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection.
    Schirren CA, Jung M, Worzfeld T, Mamin M, Baretton GB, Gruener NH, Gerlach JT, Diepolder HM, Zachoval R, Pape GR.
    Liver Transpl; 2000 Mar 27; 6(2):222-8. PubMed ID: 10719024
    [Abstract] [Full Text] [Related]

  • 8. Granzyme expression in fine-needle aspirates from liver allografts is increased during acute rejection.
    Kuijf ML, Kwekkeboom J, Kuijpers MA, Willems M, Zondervan PE, Niesters HG, Hop WC, Hack CE, Paavonen T, Höckerstedt K, Tilanus HW, Lautenschlager I, Metselaar HJ.
    Liver Transpl; 2002 Oct 27; 8(10):952-6. PubMed ID: 12360440
    [Abstract] [Full Text] [Related]

  • 9. Differential diagnosis of viral infections and acute rejection episodes in liver grafted patients by transplant aspiration cytology.
    Nashan B, Schlitt HJ, Ringe B, Bunzendahl H, Wittekind C, Wonigeit K, Pichlmayr R.
    Transplant Proc; 1991 Feb 27; 23(1 Pt 2):1507-8. PubMed ID: 1846473
    [No Abstract] [Full Text] [Related]

  • 10. Induction of cyclo-oxygenase-2 by acute liver allograft rejection and cytomegalovirus infection in the rat.
    Martelius TJ, Wolff H, Bruggeman CA, Höckerstedt KA, Lautenschlager IT.
    Transpl Int; 2002 Dec 27; 15(12):610-4. PubMed ID: 12478407
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
    Charlton M, Seaberg E.
    Liver Transpl Surg; 1999 Jul 27; 5(4 Suppl 1):S107-14. PubMed ID: 10431024
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. An assessment of interactions between hepatitis C virus and herpesvirus reactivation in liver transplant recipients using molecular surveillance.
    Humar A, Washburn K, Freeman R, Paya CV, Mouas H, Alecock E, Razonable RR, PV16000 Study Group.
    Liver Transpl; 2007 Oct 27; 13(10):1422-7. PubMed ID: 17902128
    [Abstract] [Full Text] [Related]

  • 17. Cytomegalovirus infection of the liver transplant: virological, histological, immunological, and clinical observations.
    Lautenschlager I, Halme L, Höckerstedt K, Krogerus L, Taskinen E.
    Transpl Infect Dis; 2006 Mar 27; 8(1):21-30. PubMed ID: 16623817
    [Abstract] [Full Text] [Related]

  • 18. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C.
    Burak KW, Kremers WK, Batts KP, Wiesner RH, Rosen CB, Razonable RR, Paya CV, Charlton MR.
    Liver Transpl; 2002 Apr 27; 8(4):362-9. PubMed ID: 11965581
    [Abstract] [Full Text] [Related]

  • 19. Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation.
    Zekri AR, Mohamed WS, Samra MA, Sherif GM, El-Shehaby AM, El-Sayed MH.
    Transpl Immunol; 2004 Dec 27; 13(4):305-11. PubMed ID: 15589744
    [Abstract] [Full Text] [Related]

  • 20. Early intragraft inflammatory events of liver allografts leading to chronic rejection.
    Lautenschlager I, Nashan B, Schlitt HJ, Ringe B, Wonigeit K, Pichlmayr R.
    Transpl Int; 1995 Dec 27; 8(6):446-51. PubMed ID: 8579735
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.